Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis. (Q48886048)
Jump to navigation
Jump to search
scientific article published in May 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis. |
scientific article published in May 2005 |
Statements
1 reference
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis. (English)
1 reference
Peter Rieckmann
1 reference
N Kruse
1 reference
L Nagelkerken
1 reference
K Beckmann
1 reference
D Miller
1 reference
C Polman
1 reference
F Dahlke
1 reference
K V Toyka
1 reference
H P Hartung
1 reference
S Stürzebecher
1 reference
1 May 2005
1 reference
1 reference
252
1 reference
5
1 reference
526-533
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference